Penetration promoting and eyesight improving eye drop

A kind of eye drops, transparent technology, applied in the direction of anti-inflammatory agents, non-central analgesics, medical preparations of non-active ingredients, etc., can solve the problems of eye disease treatment cycle lengthening, delayed treatment, and less active ingredients, and achieve relief Mental burden and economic burden, shortening of treatment cycle, effect of improving treatment effect

Inactive Publication Date: 2010-10-20
崔浩
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to solve the problem that the existing eye drops are generally blocked by the blood-ocular barrier, corneal barrier and ocular surface barrier, and the active ingredients that can really enter the inside of the eyeball are very few, so that the treatment period of eye diseases is lengthened or the treatment is delayed. problem, providing a hyaline-promoting eye drop

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0015] Specific embodiment one: the eye drop of this embodiment is made up of hyaline-promoting drug and drug base, the weight ratio of promoting hyaline drug to drug base is 0.01~3.5:100, and the promoting hyaline drug is borneol, menthol, oxalic acid, etc. Any combination of one or more than two (including two) of sulfochodeoxycholic acid or tauroursodeoxycholic acid. The drug base is divided into water base, cream base and gelatin base. The water base is distilled water and spit Temperature 80; ointment base is lanolin, ophthalmic petroleum jelly; gelatin base is sodium hyaluronate or methylcellulose.

specific Embodiment approach 2

[0016] Embodiment 2: The hyaline-stimulating drug described in this embodiment is borneol and menthol, and the weight ratio of borneol to menthol is 1-100:100-1, and the others are the same as in embodiment 1.

specific Embodiment approach 3

[0017] Embodiment 3: The hyaline-stimulating drug in this embodiment is borneol and menthol, and the weight ratio of borneol to menthol is 1:99, and the other is the same as in embodiment 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an eye drop, in particular to a penetration promoting and eyesight improving eye drop. The invention aims to solve the problem of treatment period prolongation of an eye disease due to less effective components of the traditional eye drop, which really enter the inner side of an eyeball, by the isolation of a blood-eye barrier, a cornea barrier and an eye surface barrier. A penetration promoting and eyesight improving medicament in the first scheme is any combination of one or more of borneol, menthol, taurochenodeoxycholic acid or tauroursodeoxycholic acid; and a penetration promoting and eyesight improving medicament in the second technical scheme is any combination of one or more of borneol, menthol, chenodeoxycholic acid or ursodesoxycholic acid. The eye drop is used for a patient with conjunctivitis, keratitis and uveitis and used as a penetration promoting agent of other eye drops or an ophthalmic pharmaceutical partner for increasing the amount of the eye drops dropping in eyes. The eye drop can penetrate through the blood-eye barrier, the cornea barrier and the eye surface barrier; and compared with the prior art, the invention can improve the effective component entering the inner side of the eyeballs by 10-200 percent.

Description

technical field [0001] The invention relates to an eye drop medicine. Background technique [0002] Existing eye drops are generally blocked by the blood-ocular barrier, corneal barrier and ocular surface barrier, and there are very few active ingredients that can really enter the inside of the eyeball, prolonging or delaying the treatment cycle of eye diseases, increasing the patient's mental burden and economic burden. Contents of the invention [0003] The purpose of the present invention is to solve the problem that the existing eye drops are generally blocked by the blood-ocular barrier, corneal barrier and ocular surface barrier, and the active ingredients that can really enter the inside of the eyeball are very few, so that the treatment period of eye diseases is lengthened or the treatment is delayed. To solve the problem, a hyaline-promoting eye drop is provided. [0004] The eye drops of the first technical solution of the present invention are composed of a hy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/045A61K31/575A61K47/10A61K47/28A61K9/00A61P27/02A61P29/00
Inventor 崔浩
Owner 崔浩
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap